Comment
. 2004 Aug 25;292(8):922; author reply 922-3.
doi: 10.1001/jama.292.8.922-a.
Disparities in participation in cancer clinical trials
- PMID: 15328321
- DOI: 10.1001/jama.292.8.922-a
Item in Clipboard
Comment
Disparities in participation in cancer clinical trials
JAMA.
.
No abstract available
Comment on
-
Participation in cancer clinical trials: race-, sex-, and age-based disparities.JAMA. 2004 Jun 9;291(22):2720-6. doi: 10.1001/jama.291.22.2720. JAMA. 2004. PMID: 15187053
Similar articles
-
Participation in cancer trials: recruitment of underserved populations.Clin Adv Hematol Oncol. 2003 Oct;1(10):607-13. Clin Adv Hematol Oncol. 2003. PMID: 16258457 Review.
-
Increasing participation of minorities in cancer clinical trials: summary of the "Moving Beyond the Barriers" Conference in North Carolina.J Natl Med Assoc. 2002 Jan;94(1):31-9. J Natl Med Assoc. 2002. PMID: 11837350 Free PMC article. Review.
-
Bringing cures to all patients: addressing diversity in clinical trials.ONS Connect. 2007;22(8 Suppl):5-6. ONS Connect. 2007. PMID: 17824541 No abstract available.
-
Clinical trials in cancer.Lancet. 1982 Aug 21;2(8295):439. doi: 10.1016/s0140-6736(82)90466-4. Lancet. 1982. PMID: 6124826 No abstract available.
-
Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy.J Clin Oncol. 2006 May 10;24(14):2209-15. doi: 10.1200/JCO.2005.04.8116. J Clin Oncol. 2006. PMID: 16682741 Review.
Cited by
-
Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis.Cancer. 2012 Sep 1;118(17):4309-20. doi: 10.1002/cncr.27422. Epub 2012 Jan 31. Cancer. 2012. PMID: 22294436 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
